C-Terminal glycine is crucial for hyperalgesic activity of nociceptin/orphanin FQ-(1-6)

Citation
J. Kotlinska et al., C-Terminal glycine is crucial for hyperalgesic activity of nociceptin/orphanin FQ-(1-6), EUR J PHARM, 419(1), 2001, pp. 33-37
Citations number
27
Categorie Soggetti
Pharmacology & Toxicology
Journal title
EUROPEAN JOURNAL OF PHARMACOLOGY
ISSN journal
00142999 → ACNP
Volume
419
Issue
1
Year of publication
2001
Pages
33 - 37
Database
ISI
SICI code
0014-2999(20010504)419:1<33:CGICFH>2.0.ZU;2-Q
Abstract
A C-terminal analog of the hexapeptide orphanin FQ/nociceptin-(1-6), [Ala(6 )]-orphanin FQ/nociceptin-(1-6), and a pentapeptide orphanin FQ/nociceptin- (1-5) were tested in vivo for their analgesic/hyperalgesic activity in the hot-plate test with rats. Replacement of the C-terminal glycine by L-alanin e (Phe-Gly-Gly-Phe-Thr-Ala) in orphanin FQ/nociceptin-(1-6) abolished the h yperalgesic potency of native orphanin FQ/nociceptin-(1-6) (Phe-Gly-Gly-Phe -Thr-Gly), but analgesic activity was retained and was diminished by naloxo ne. Removal of the C-terminal amino acid (glycine or alanine) from orphanin FQ/nociceptin-(1-6) caused a significant loss of analgesic activity. It is anticipated that glycine plays a crucial role in the biphasic activity of orphanin FQ/nociceptin-(1-6). This may suggest the existence of a mechanism for terminating the biological action of orphanin FQ/nociceptin. (C) 2001 Elsevier Science B.V. All rights reserved.